Subscribe To
NXTC / NextCure to Present at the JMP Securities Life Sciences Conference
BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the JMP Securities Life Sciences Conference in New York City on Tuesday, May 16th, at 11:30 am ET.
Read More
Posted: May 9 2023, 07:00
Author Name: GlobeNewsWire
Views: 082111
NXTC News
By GlobeNewsWire
May 9, 2023
NextCure to Present at the JMP Securities Life Sciences Conference
BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering a more_horizontal